Treatment Modification After Initiating Second-Line Medication for Type 2 Diabetes
AJMC,
ABSTRACT Objectives: To describe changes in antidiabetic medication (ADM) use and characteristics associated with changes in…
糖尿病治療薬「セマグルチド」の使用をやめてしまう患者が多い理由
wired,
肥満研究の領域でセンセーショナルな論文が発表されたのは2021年2月のことである。その論文は肥満治療のためにセマグルチド（商品名である「オゼンピック」や「ウゴービ」の一般名）を毎週患者に投与した初の臨床試験の結果を報告するものだった。薬を注射した人の体重は平…
Why People Stop Using Drugs Like Ozempic - News Azi
News Azi,
That isn’t surprising, says John Wilding, an obesity researcher at the University of Liverpool who led a major study on the use…
Why People Stop Using Drugs Like Ozempic
Wired.com,
Drugs like semaglutide—better known as Ozempic or Wegovy—could be lifelong treatments for obesity, but what little data…
Docs Debate Insulin vs GLP-1 Agonist as First Injectable for T2D
Medscape,
BUSAN, SOUTH KOREA — The choice of first injectable medication to use in type 2 diabetes is still a matter of debate, despite…
Docs Debate Insulin vs GLP-1 Agonist as First Injectable for T2D
Medscape,
BUSAN, SOUTH KOREA — The choice of first injectable medication to use in type 2 diabetes is still a matter of debate, despite…